Jan. 27 Business Watch: Vioneo moves project to China; GSK to buy Rapt Therapeutics for $2.2 billion

GSK plans to acquire Rapt Therapeutics for $2.2 billion while Vioneo relocates a project to China; concurrently, a US snowstorm highlights the essential role of chemical remedies in public safety.